FDA approves Nucala to treat severe asthma – FDA.gov

FDA approves Nucala to treat severe asthma
FDA.gov
The U.S. Food and Drug Administration today approved Nucala (mepolizumab) for use with other asthma medicines for the maintenance treatment of asthma in patients age 12 years and older. Nucala is approved for patients who have a history of severe …
FDA Approves New Asthma MedicationMedPage Today

all 2 news articles »